Dynatrace raises target price to $70 from $62
DT•Rosenblatt Securities raised its target price for Dynatrace to $70 from $62.
Related News
aTyr Pharma's efzofitimod misses primary endpoint in Phase 3 pulmonary sarcoidosis trial
ATYR•
Borr Drilling reports three bodies located after Prospector 5 incident offshore Gabon
BORR•
Corvus Pharmaceuticals to report third-quarter financial results
CRVS•
FDA clears Eloxx's Exaluren for Phase 2 trial in ADPKD
ELOX•
Ameriprise Financial declares quarterly dividend of $1.70 per share
AMP•